Search

everythinglearnresearchcommunity

for

Search:↓

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.